Thermo Fisher Scientific (TMO) Total Current Liabilities (2016 - 2025)
Thermo Fisher Scientific's Total Current Liabilities history spans 17 years, with the latest figure at $15.2 billion for Q4 2025.
- For the quarter ending Q4 2025, Total Current Liabilities rose 13.93% year-over-year to $15.2 billion, compared with a TTM value of $15.2 billion through Dec 2025, up 13.93%, and an annual FY2025 reading of $15.2 billion, up 13.93% over the prior year.
- Total Current Liabilities for Q4 2025 was $15.2 billion at Thermo Fisher Scientific, up from $14.9 billion in the prior quarter.
- The five-year high for Total Current Liabilities was $17.0 billion in Q4 2022, with the low at $6.9 billion in Q3 2021.
- Average Total Current Liabilities over 5 years is $12.9 billion, with a median of $13.7 billion recorded in 2021.
- Year-over-year, Total Current Liabilities surged 72.55% in 2022 and then decreased 17.62% in 2023.
- Tracing TMO's Total Current Liabilities over 5 years: stood at $13.4 billion in 2021, then rose by 26.6% to $17.0 billion in 2022, then fell by 17.62% to $14.0 billion in 2023, then decreased by 4.85% to $13.3 billion in 2024, then rose by 13.93% to $15.2 billion in 2025.
- Per Business Quant, the three most recent readings for TMO's Total Current Liabilities are $15.2 billion (Q4 2025), $14.9 billion (Q3 2025), and $12.7 billion (Q2 2025).